SeekingAlpha  Aug 2  Comment 
SeekingAlpha  Jul 25  Comment 
Motley Fool  Jun 18  Comment 
Centennial Resource Development, Celldex Therapeutics, and Cott could be multibaggers, but each carries its own brand of speculative risk.
Motley Fool  Jun 17  Comment 
Cheniere Energy, National Beverage, and Cott all have the potential to do very well in the next decade.
Benzinga  Jun 7  Comment 
BMO Capital Markets is favoring growth stories over blue-chip value as BMO analyst Amit Sharma re-rated several companies in the beverage sector. DPS: Upgraded to Outperform, raised price target to $105 Sharma believes Dr. Pepper Snapple...

You may also be interested in articles related to Cott (COT):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki